Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
~61 mi.
(Kraków,
Poland,
+150 more cities)
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 0905)
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
~61 mi.
(Kraków,
Poland,
+137 more cities)
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 0959)
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)
~61 mi.
(Kraków,
Poland,
+127 more cities)
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 2502)
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
~61 mi.
(Kraków,
Poland,
+92 more cities)
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 0153)
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
~61 mi.
(Kraków,
Poland,
+145 more cities)
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 2400)
Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis
~61 mi.
(Kraków,
Poland,
+189 more cities)
SP ZOZ Szpital Uniwersytecki w Krakowie /ID# 221160
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma